Ondine Biomedical Inc (LON:OBIMF) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55422	Articles
62513	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

BRIEF

published on 06/21/2024 at 08:05, 5 months ago

Ondine Biomedical Inc – Steriwave now available through NHS Supply Chain

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS Supply Chain
PRESS RELEASE

published on 06/21/2024 at 08:00, 5 months ago

Ondine Biomedical Inc - Steriwave now available through NHS Supply Chain
Ondine Biomedical Inc. announces Steriwave® nasal photodisinfection availability through NHS Supply Chain in England and Wales, offering innovative antimicrobial treatment to prevent infections

Ondine Biomedical Inc. Steriwave Antimicrobial Treatment NHS Supply Chain Nasal Photodisinfection
BRIEF

published on 05/28/2024 at 08:05, 5 months 24 days ago

Ondine Biomedical Inc Announces Notice of Results, Investor Presentation, and AGM

Ondine Biomedical Inc. Investor Presentation Annual Report AGM Full Year Results
PRESS RELEASE

published on 05/28/2024 at 08:00, 5 months 24 days ago

Ondine Biomedical Inc Announces Notice of Results, Investor Presentation, and AGM
Ondine Biomedical Inc. to release Full Year Results and Annual Report 2023 on 7 June 2024. Live presentation by Dr. Nicolas Loebel on 10 June 2024 via Investor Meet Company

Ondine Biomedical Inc. Photodisinfection Therapies Full Year Results Annual Report 2023 Investor Meet Company
BRIEF

published on 05/10/2024 at 08:05, 6 months 11 days ago

Ondine Biomedical Inc Announces Rising HAIs and Antibiotic Resistance

Antibiotic Resistance Steriwave Technology Healthcare-associated Infections ECDC Report Antimicrobial Stewardship
PRESS RELEASE

published on 05/10/2024 at 08:00, 6 months 11 days ago

Ondine Biomedical Inc Announces ECDC Report Shows Rising HAIs and Antibiotic Use
ECDC report reveals rise in antibiotic-resistant HAIs, emphasizing Ondine Biomedical's light-activated antimicrobial technology. The technology offers a solution to combat antimicrobial resistance by killing all types of pathogens without causing resistance

Ondine Biomedical Antibiotic Resistance Antimicrobial Technology ECDC Report HAIs
BRIEF

published on 04/25/2024 at 08:05, 6 months 26 days ago

Ondine Biomedical Inc Reveals Potential Key Source of Surgical Infections

Antimicrobial Resistance Nasal Decolonization Steriwave Ondine Biomedical Surgical Infections
PRESS RELEASE

published on 04/25/2024 at 08:00, 6 months 26 days ago

Ondine Biomedical Inc Announces New Study Confirms Nose Is Key Source of Infection
Ondine Biomedical Inc. releases new independent research showing 86% of surgical site infections caused by patient microbiome bacteria from nose, skin, or gut, with 59% resistant to antibiotics

Ondine Biomedical Inc. Nasal Decolonization Antibiotic Resistance Healthcare-associated Infections Surgical Site Infections
BRIEF

published on 04/24/2024 at 08:05, 6 months 27 days ago

Ondine Biomedical Inc Announces Corporate and Trading Update

Revenue Growth Clinical Trials Steriwave Technology Ondine Biomedical Inc Hospital Infections
PRESS RELEASE

published on 04/24/2024 at 08:00, 6 months 27 days ago

Ondine Biomedical Inc Announces Corporate and Trading Update
Ondine Biomedical (LON:OBI) reports significant revenue growth and commercial momentum in 2023 with doubled revenues and increased number of hospital deployments, including strategic inroads in the UK, Spain, and Australia. The company also announces distribution partnerships and plans for US Phase 3 Clinical Trial

Revenue Growth Ondine Biomedical Distribution Partnerships Hospital Deployments US Phase 3 Clinical Trial

Accesswire

Published on 11/21/2024 at 17:35, 1 hour 6 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 11 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 11 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 40 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 41 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 18:36, 5 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 42 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 49 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 50 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 41 minutes ago

Director/PDMR Shareholding

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE